Search research articles
Contact Us
Filters
Showing results (201-210 of 288) with videos related to
Page
of 29
Sort By:
Journal of Ovarian Research
|
November 2, 2021
Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
M Liontos, A Andrikopoulou, K Koutsoukos, et al.
Urology
|
December 31, 1997
Oral estramustine and oral etoposide for hormone-refractory prostate cancer
M A Dimopoulos, C Panopoulos, C Bamia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 26, 2005
The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy
A Bamias, E Efstathiou, L A Moulopoulos, et al.
Leukemia
|
September 19, 2013
VTD consolidation, without bisphosphonates, reduces bone resorption and is associated with a very low incidence of skeletal-related events in myeloma patients post ASCT
E Terpos, D Christoulas, E Kastritis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: a multicenter phase II study
N Androulakis, C Kourousis, M A Dimopoulos, et al.
British Journal of Cancer
|
June 1, 2013
Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series
F Zagouri, T N Sergentanis, V Koutoulidis, et al.
Journal of Surgical Oncology
|
October 31, 2009
Thymidine phosphorylase to dihydropyrimidine dehydrogenase ratio as a predictive factor of response to preoperative chemoradiation with capecitabine in patients with advanced rectal cancer
C S Boskos, C Liacos, D Korkolis, et al.
British Journal of Cancer
|
February 21, 2013
High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer
F Zagouri, Z Bago-Horvath, F Rössler, et al.
Leukemia
|
November 28, 2012
Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease
E Kastritis, E Terpos, L Moulopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1997
Long-range amplification of genomic DNA detects the t(2;5)(p23;q35) in anaplastic large-cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis
A H Sarris, R Luthra, V Papadimitracopoulou, et al.
Page
of 29
Search research articles
Search
Showing results (201-210 of 288) with videos related to
Sort By:
Page
of 29
Journal of Ovarian Research
|
November 2, 2021
Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
M Liontos, A Andrikopoulou, K Koutsoukos, et al.
Urology
|
December 31, 1997
Oral estramustine and oral etoposide for hormone-refractory prostate cancer
M A Dimopoulos, C Panopoulos, C Bamia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 26, 2005
The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy
A Bamias, E Efstathiou, L A Moulopoulos, et al.
Leukemia
|
September 19, 2013
VTD consolidation, without bisphosphonates, reduces bone resorption and is associated with a very low incidence of skeletal-related events in myeloma patients post ASCT
E Terpos, D Christoulas, E Kastritis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: a multicenter phase II study
N Androulakis, C Kourousis, M A Dimopoulos, et al.
British Journal of Cancer
|
June 1, 2013
Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series
F Zagouri, T N Sergentanis, V Koutoulidis, et al.
Journal of Surgical Oncology
|
October 31, 2009
Thymidine phosphorylase to dihydropyrimidine dehydrogenase ratio as a predictive factor of response to preoperative chemoradiation with capecitabine in patients with advanced rectal cancer
C S Boskos, C Liacos, D Korkolis, et al.
British Journal of Cancer
|
February 21, 2013
High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer
F Zagouri, Z Bago-Horvath, F Rössler, et al.
Leukemia
|
November 28, 2012
Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease
E Kastritis, E Terpos, L Moulopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1997
Long-range amplification of genomic DNA detects the t(2;5)(p23;q35) in anaplastic large-cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis
A H Sarris, R Luthra, V Papadimitracopoulou, et al.
Page
of 29